Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes

NCT03361631 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Erectile Dysfunction
Stem Cells
Diabetes Mellitus, Type 1

Interventions

DRUG: Autologous Bone Marrow derived Mesenchymal Stem Cells

Sponsor

Central Hospital, Nancy, France